Please use this identifier to cite or link to this item: https://hdl.handle.net/10316/111786
Title: Fully Automated Production of [68Ga]GaFAPI-46 with Gallium-68 from Cyclotron Using Liquid Targets
Authors: Fonseca, Alexandra I. 
Alves, Vítor H. 
Hrynchak, Ivanna 
Alves, Francisco 
Keywords: radiopharmaceuticals; cyclotron; liquid targets; GaFAPI-46
Issue Date: 12-Oct-2023
Publisher: MDPI
Project: PD/BDE/150681/2020 
PD/BDE/150331/2019 
ICNAS-P. 
Serial title, monograph or event: International Journal of Molecular Sciences
Volume: 24
Issue: 20
Abstract: 68Ga-based radiopharmaceuticals are routinely used for PET imaging of multiple types of tumors. Gallium-68 is commonly obtained from 68Ge/68Ga generators, which are limited in the quantity of activity produced. Alternatively, gallium-68 can easily be produced on a cyclotron using liquid targets. In this study, we optimized the GMP production of [68Ga]GaFAPI-46 using gallium-68 produced via a standard medical cyclotron using liquid targets. Starting from the published synthesis and quality control procedures described for other 68Ga-based radiopharmaceuticals, we have validated the synthesis process and the analytical methods to test the quality parameters of the final product to be used for routine clinical studies. [68Ga]GaFAPI-46 was successfully produced with high radiochemical purity and yield using an IBA Synthera® Extension module. Gallium chloride was produced on a medical cyclotron using a liquid target with activity of 4.31 ± 0.36 GBq at the end of purification (EOP). Analytical methods were established and validated, meeting Ph. Eur. standards. Full GMP production was also validated in three consecutive batches, producing 2.50 ± 0.46 GBq of [68Ga]GaFAPI-46 at the end of synthesis (EOS), with 98.94 ± 0.72% radiochemical purity measured via radio-HPLC. Quality was maintained for up to 3 h after the EOS. Production of [68Ga]GaFAPI-46 was performed and validated using a standard medical cyclotron with liquid targets. The quality control parameters (e.g., sterility, purity, and residual solvents) conformed to Ph. Eur. and a shelf life of 3 h was established. The activity of [68Ga]GaFAPI-46 produced was substantially higher than the one obtained with generators, enabling a better response to the clinical need for this radiopharmaceutical.
URI: https://hdl.handle.net/10316/111786
ISSN: 1422-0067
DOI: 10.3390/ijms242015101
Rights: openAccess
Appears in Collections:I&D CIBIT - Artigos em Revistas Internacionais
I&D ICNAS - Artigos em Revistas Internacionais

Show full item record

Page view(s)

32
checked on Apr 17, 2024

Download(s)

11
checked on Apr 17, 2024

Google ScholarTM

Check

Altmetric

Altmetric


This item is licensed under a Creative Commons License Creative Commons